274 related articles for article (PubMed ID: 16698948)
21. The role of immunohistochemistry in the differential diagnosis of breast lesions.
Moriya T; Kozuka Y; Kanomata N; Tse GM; Tan PH
Pathology; 2009 Jan; 41(1):68-76. PubMed ID: 19089742
[TBL] [Abstract][Full Text] [Related]
22. [Papillary lesions of the breast].
Ni YB; Tse GM
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):721-6. PubMed ID: 24447546
[No Abstract] [Full Text] [Related]
23. Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions.
Mosunjac MB; Lewis MM; Lawson D; Cohen C
Diagn Cytopathol; 2000 Sep; 23(3):151-5. PubMed ID: 10945900
[TBL] [Abstract][Full Text] [Related]
24. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study.
Ozolek JA; Barnes EL; Hunt JL
Arch Pathol Lab Med; 2007 Apr; 131(4):530-7. PubMed ID: 17425380
[TBL] [Abstract][Full Text] [Related]
25. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
[TBL] [Abstract][Full Text] [Related]
26. New trends of immunohistochemistry for making differential diagnosis of breast lesions.
Moriya T; Kasajima A; Ishida K; Kariya Y; Akahira J; Endoh M; Watanabe M; Sasano H
Med Mol Morphol; 2006 Mar; 39(1):8-13. PubMed ID: 16575508
[TBL] [Abstract][Full Text] [Related]
27. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
Ding Y; Ruan Q
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
[TBL] [Abstract][Full Text] [Related]
28. Basal cytokeratin phenotypes of myoepithelial cells indicates the origin of ductal carcinomas in situ of the breast.
Chen L; Yin X; Lu S; Chen G; Dong L
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):558-64. PubMed ID: 26336082
[TBL] [Abstract][Full Text] [Related]
29. An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas.
Wang Y; Zhu JF; Liu YY; Han GP
Diagn Pathol; 2013 Jan; 8():8. PubMed ID: 23327593
[TBL] [Abstract][Full Text] [Related]
30. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
31. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
[TBL] [Abstract][Full Text] [Related]
32. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Leibl S; Moinfar F
Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
[TBL] [Abstract][Full Text] [Related]
33. p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Alvarenga M; Vassallo J
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):71-7. PubMed ID: 16540734
[TBL] [Abstract][Full Text] [Related]
34. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain.
Kalof AN; Tam D; Beatty B; Cooper K
J Clin Pathol; 2004 Jun; 57(6):625-9. PubMed ID: 15166269
[TBL] [Abstract][Full Text] [Related]
35. Papillomatous breast lesions with atypical columnar cell features.
de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
[TBL] [Abstract][Full Text] [Related]
36. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.
Saddik M; Lai R
J Clin Pathol; 1999 Nov; 52(11):862-4. PubMed ID: 10690183
[TBL] [Abstract][Full Text] [Related]
37. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
Furuya C; Kawano H; Yamanouchi T; Oga A; Ueda J; Takahashi M
Pathol Int; 2012 Jun; 62(6):381-90. PubMed ID: 22612506
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic evaluation of papillary lesions of the breast on core biopsy.
Pathmanathan N; Albertini AF; Provan PJ; Milliken JS; Salisbury EL; Bilous AM; Byth K; Balleine RL
Mod Pathol; 2010 Jul; 23(7):1021-8. PubMed ID: 20473278
[TBL] [Abstract][Full Text] [Related]
39. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
[TBL] [Abstract][Full Text] [Related]
40. Central atypical papillomas of the breast: a clinicopathological study of 119 cases.
MacGrogan G; Tavassoli FA
Virchows Arch; 2003 Nov; 443(5):609-17. PubMed ID: 13680220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
